
New specialists' schedules fill quickly, the authors of an NEJM Catalyst analysis write, and changing how existing clinicians are used may do more to shorten waits.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
GLP-1 RA drugs are an important step in changing the




